<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02548091</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00399-40</org_study_id>
    <nct_id>NCT02548091</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Edema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary Hypertension</brief_title>
  <acronym>OPR_VNI</acronym>
  <official_title>Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Oedema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Chirurgical Marie Lannelongue</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Chirurgical Marie Lannelongue</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Non Invasive Ventilation are effective in&#xD;
      prevention of reperfusion pulmonary edema after pulmonary artery angioplasty. Our hypothesis&#xD;
      is that administration of Non Invasive Ventilation during the procedure and systematically in&#xD;
      post procedure period is a protective factor against the development and severity of&#xD;
      reperfusion pulmonary edema.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 1, 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lung Injury Score.</measure>
    <time_frame>Daily during hospitalization in the PACU on day 1 to 7.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assays of plasma inflammatory markers (InterLeukin-6 , IInterLeukin-8, InterLeukin-10).</measure>
    <time_frame>2 years</time_frame>
    <description>The concentration will be given in pg/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extravascular Lung Water (EVLW) measures.</measure>
    <time_frame>2 years</time_frame>
    <description>EVLW is measure by thermodilution technique using a Pulse-Induced Contour Cardiac Output system (PICCO). The unit of EVLW is mL/Kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Computed tomography (CT) score</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Doppler pulsatility of the portal vein and its pulsatility ratio</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary Vascular Index (PVI) measures</measure>
    <time_frame>2 years</time_frame>
    <description>PVI is measure by thermodilution technique using a Pulse-Induced Contour Cardiac Output system (PICCO</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">236</enrollment>
  <condition>Reperfusion Pulmonary Edema</condition>
  <arm_group>
    <arm_group_label>Preventive non invasive ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive the non invasive ventilation (NIV) systematically during the whole procedure of pulmonary angioplasty, and then systematically in post procedure period, 1 hour every 4 hours, during the whole hospitalization in post anesthesia care unit (PACU).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non invasive ventilation on demand</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will not receive the NIV during the procedure of pulmonary angioplasty; in case of respiratory decompensation in post procedure period they will receive NIV during the whole hospitalization in PACU according to the following criteria: paradoxical breathing, respiratory rate above 25/minutes, a ratio of arterial oxygen pressure to fraction of inspired oxygen values (PaO2/FiO2) below 200.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood samples for assays of plasma inflammatory markers (cytokines InterLeukin-6, InterLeukin-8, InterLeukin-10)</intervention_name>
    <description>The same amount of blood sample is collected from both arms of study at the same time of the procedure.&#xD;
In each patient, in the per procedure period, a total of 50 milliliters of blood sample is drawn from the pulmonary circulation downstream and upstream of obstructive lesion, the trunk of pulmonary artery, the superior vena cava and the femoral arterial line prior to angioplasty and at the end of procedure; in the post interventional care unit 10 milliliters of blood sample will be draw daily from the superior vena cava catheter line and femoral arterial line.</description>
    <arm_group_label>Non invasive ventilation on demand</arm_group_label>
    <arm_group_label>Preventive non invasive ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non invasive ventilation</intervention_name>
    <arm_group_label>Non invasive ventilation on demand</arm_group_label>
    <arm_group_label>Preventive non invasive ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>monitoring system Pulse-Induced Contour Cardiac Output (Picco)</intervention_name>
    <arm_group_label>Non invasive ventilation on demand</arm_group_label>
    <arm_group_label>Preventive non invasive ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Computed tomography (CT)</intervention_name>
    <arm_group_label>Non invasive ventilation on demand</arm_group_label>
    <arm_group_label>Preventive non invasive ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  First and /or second procedure of pulmonary artery angioplasty&#xD;
&#xD;
          -  Mean pulmonary arterial pressure ≥ 40 mmHg and/or pulmonary vascular resistance ≥ 8 WU&#xD;
             (Wood unit)&#xD;
&#xD;
          -  Patient who signed informed consent&#xD;
&#xD;
          -  Patients affiliated to a social security program&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  severe neurological disease: Coma Glasgow Scale &lt; 8, severe cognitive decline,&#xD;
             postural instability, loss of autonomy.&#xD;
&#xD;
          -  psychiatric disease (illness)&#xD;
&#xD;
          -  sepsis, severe sepsis and septic shock, according to definitions and diagnostic&#xD;
             criteria for sepsis of 'Surviving Sepsis Campaign 2012'&#xD;
&#xD;
          -  severe respiratory failure defined by a total lung capacity (TLC)&lt; 50% of the&#xD;
             predicted value and/or expiratory volume in 1 second (FEV) &lt; 30% of predicted value&#xD;
&#xD;
          -  obstructive sleep apnea syndrome with Continuous Positive Airway treatment&#xD;
&#xD;
          -  preexisting hemorrhagic syndrome or coagulation factors deficiency&#xD;
&#xD;
          -  severe renal insufficiency with glomerular filtration rate &lt; 30 ml/min&#xD;
&#xD;
          -  severe hepatic failure with hepatic encephalopathy, hemodynamic disorder,&#xD;
             decompensates cirrhosis, metabolic disorder( metabolic acidosis, hypoglycemia)&#xD;
             hepatorenal syndrome, coagulation disorder (factor V&lt; 50%,disseminated intravascular&#xD;
             coagulation)&#xD;
&#xD;
          -  patient refusal of participation in the study program&#xD;
&#xD;
          -  subjects not affiliated to social security program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>PATRASCU ALINA, MD</last_name>
    <phone>01 40 94 25 97</phone>
    <email>a.patrascu@ccml.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Chirurgical Marie Lannelongue</name>
      <address>
        <city>Le Plessis Robinson</city>
        <zip>92350</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>September 3, 2015</study_first_submitted>
  <study_first_submitted_qc>September 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2015</study_first_posted>
  <last_update_submitted>October 12, 2017</last_update_submitted>
  <last_update_submitted_qc>October 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non invasive ventilation</keyword>
  <keyword>reperfusion pulmonary edema</keyword>
  <keyword>chronic thrombolic pulmonary hypertension</keyword>
  <keyword>pulmonary artery angioplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

